JPH11240832A5 - - Google Patents

Info

Publication number
JPH11240832A5
JPH11240832A5 JP1998290734A JP29073498A JPH11240832A5 JP H11240832 A5 JPH11240832 A5 JP H11240832A5 JP 1998290734 A JP1998290734 A JP 1998290734A JP 29073498 A JP29073498 A JP 29073498A JP H11240832 A5 JPH11240832 A5 JP H11240832A5
Authority
JP
Japan
Prior art keywords
alk
group
optionally substituted
pyrazol
bond
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1998290734A
Other languages
English (en)
Japanese (ja)
Other versions
JP4385414B2 (ja
JPH11240832A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP29073498A priority Critical patent/JP4385414B2/ja
Priority claimed from JP29073498A external-priority patent/JP4385414B2/ja
Publication of JPH11240832A publication Critical patent/JPH11240832A/ja
Publication of JPH11240832A5 publication Critical patent/JPH11240832A5/ja
Application granted granted Critical
Publication of JP4385414B2 publication Critical patent/JP4385414B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP29073498A 1997-10-13 1998-10-13 アミド若しくはアミン誘導体 Expired - Lifetime JP4385414B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP29073498A JP4385414B2 (ja) 1997-10-13 1998-10-13 アミド若しくはアミン誘導体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP9-279093 1997-10-13
JP27909397 1997-10-13
JP29073498A JP4385414B2 (ja) 1997-10-13 1998-10-13 アミド若しくはアミン誘導体

Publications (3)

Publication Number Publication Date
JPH11240832A JPH11240832A (ja) 1999-09-07
JPH11240832A5 true JPH11240832A5 (enExample) 2005-04-21
JP4385414B2 JP4385414B2 (ja) 2009-12-16

Family

ID=26553175

Family Applications (1)

Application Number Title Priority Date Filing Date
JP29073498A Expired - Lifetime JP4385414B2 (ja) 1997-10-13 1998-10-13 アミド若しくはアミン誘導体

Country Status (1)

Country Link
JP (1) JP4385414B2 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6506747B1 (en) * 1998-06-05 2003-01-14 Boehringer Ingelheim Pharmaceuticals, Inc. Substituted 1-(4-aminophenyl)pyrazoles and their use as anti-inflammatory agents
IL145508A0 (en) * 1999-03-26 2002-06-30 Euro Celtique Sa Aryl substituted pyrazole, imidazole, oxazole, thiazole and pyrrole derivatives and pharmaceutical compositions containing the same
EP1292577B1 (en) * 2000-03-24 2012-10-24 Euro-Celtique S.A. Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
JP4083422B2 (ja) * 2000-12-22 2008-04-30 石原産業株式会社 アニリン誘導体またはその塩ならびにそれらを含有するサイトカイン産生抑制剤
EP1725544B1 (en) * 2004-03-09 2009-05-27 Boehringer Ingelheim Pharmaceuticals Inc. 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
AU2006208045B2 (en) 2005-01-25 2012-08-30 Synta Pharmaceuticals Corp. Compounds for inflammation and immune-related uses
WO2006081389A1 (en) * 2005-01-25 2006-08-03 Synta Pharmaceuticals Corp. Thiophene compounds for inflammation and immune-related uses
EP2465850B1 (en) 2006-02-28 2016-11-23 Dart Neuroscience (Cayman) Ltd Therapeutic compounds
US8779154B2 (en) 2006-09-26 2014-07-15 Qinglin Che Fused ring compounds for inflammation and immune-related uses
US8222243B2 (en) 2007-08-27 2012-07-17 Dart Neuroscience (Cayman) Ltd Therapeutic isoxazole compounds
US8399436B2 (en) * 2009-04-24 2013-03-19 Glaxo Group Limited N-pyrazolyl carboxamides as CRAC channel inhibitors
US8993612B2 (en) * 2009-10-08 2015-03-31 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel and methods for treatment of non-small cell lung cancer
US8377970B2 (en) * 2009-10-08 2013-02-19 Rhizen Pharmaceuticals Sa Modulators of calcium release-activated calcium channel
EP2563759B1 (en) * 2010-04-27 2022-04-06 Calcimedica, Inc. Compounds that modulate intracellular calcium

Similar Documents

Publication Publication Date Title
JP2005536458A5 (enExample)
US7285554B2 (en) Pyrazole derivative
US5776954A (en) Substituted pyridyl pyrroles, compositions containing such compounds and methods of use
US7816558B2 (en) Triarylcarboxylic acid derivative
JP2005534627A5 (enExample)
CA2483159A1 (en) Triazole derivatives as tachykinin receptor antagonists
JP2005507918A5 (enExample)
US8822451B2 (en) Modulators of ATP-binding cassette transporters
JP2020516671A5 (enExample)
CA2484188A1 (en) Tachykinin receptor antagonists
CA2496139A1 (en) Benzimidazole derivatives
US20100240618A1 (en) Substituted piperazines
JP2006514942A5 (enExample)
JP2009523812A5 (enExample)
US20180214418A1 (en) Multisubstituted aromatic compounds as inhibitors of thrombin
JP2010513435A5 (enExample)
JP2010275317A5 (enExample)
JP2006500348A5 (enExample)
JP2007504161A5 (enExample)
JP2010513304A5 (enExample)
JP2008510828A5 (enExample)
JP2006501273A5 (enExample)
SI20208A (sl) INHIBITORJI FAKTORJA Xa Z NEVTRALNO P1 SPECIFIČNO SKUPINO
JP2006500369A5 (enExample)
RU2006123418A (ru) Новые антагонисты м3 мускаринового ацетилхолинового рецептора